药物对比
Tirzepatide vs Troglitazone
比较 Tirzepatide 与 Troglitazone 治疗糖尿病。Tirzepatide 已获批；Troglitazone 因肝衰竭已撤市。主要安全性、疗效差异。
此页面暂无可用的对比维度。
临床背景
This comparison occurs when reviewing historical TZD diabetes drugs against modern dual incretin agonists.
结论
Tirzepatide is the only viable option today since Troglitazone was withdrawn for safety reasons.
全部药物对比